- Home
- HSTM vs VIR Comparison
HSTM vs VIR Comparison
Compare HSTM & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSTM | VIR |
|---|---|---|
| Founded | 1990 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 642.6M | 1.5B |
| IPO Year | 1999 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HSTM | VIR |
|---|---|---|
| Price | $20.94 | $9.47 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $28.00 | $19.63 |
| AVG Volume (30 Days) | 336.8K | ★ 4.3M |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | ★ 0.67% | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ 0.61 | N/A |
| Revenue | ★ $304,064,000.00 | $68,556,000.00 |
| Revenue This Year | $8.95 | N/A |
| Revenue Next Year | $4.92 | $925.73 |
| P/E Ratio | $34.64 | ★ N/A |
| Revenue Growth | ★ 4.26 | N/A |
| 52 Week Low | $19.50 | $4.16 |
| 52 Week High | $34.13 | $10.91 |
Technical Indicators
Market Signals| Indicator | HSTM | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 57.65 |
| Support Level | $19.50 | $4.64 |
| Resistance Level | $22.96 | $10.91 |
| Average True Range (ATR) | 0.69 | 0.61 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 35.36 | 49.69 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.